Press Releases
SAN DIEGO--(BUSINESS WIRE)-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at three upcoming investor conferences:
Citizens JMP Life Sciences Conference Fireside Chat: Tuesday, May 14, 2024 at 1:30 p.m. Eastern Time in New York, NY
2024 RBC Capital Markets Global Healthcare Conference Fireside Chat: Wednesday, May 15, 2024 at 11:30 a.m. Eastern Time in New York, NY
BofA Securities Health Care Conference Fireside Chat:... (continue reading...)
Management Board of Northern Horizon Capital AS has approved the unaudited financial results of Baltic Horizon Fund (the Fund) for the three months of 2024.
Our strategic ambitionsOver the past year, our focus has been on reshaping our strategy to foster sustainable value, concentrating efforts on avenues that promise reliable and consistent growth for our investors. In light of prevailing market conditions, we firmly believe that the execution of the ‘Modern City... (continue reading...)
HOUSTON--(BUSINESS WIRE)-- SilverBow Resources, Inc. (NYSE: SBOW) (“SilverBow” or the “Company”) today announced that Institutional Shareholder Services (“ISS”) and Glass Lewis & Co. (“Glass Lewis”), two leading independent proxy advisory firms, have both recommended that SilverBow shareholders vote “FOR” the re-election of SilverBow’s three highly qualified and independent director nominees on the WHITE proxy card in connection with the... (continue reading...)
NEW YORK--(BUSINESS WIRE)-- KBRA assigns preliminary ratings to 56 classes of mortgage pass-through notes from GS Mortgage-Backed Securities Trust 2024-PJ5 (GSMBS 2024-PJ5). The transaction is backed by primarily prime jumbo mortgages with an aggregate principal balance of approximately $403.4 million as of the cut-off date. The pool comprises 398 first-lien, fixed rate residential mortgage loans as of the May 1, 2024 cut-off date. The pool is characterized by... (continue reading...)
HIGH POINT, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of an adjunctive therapy to insulin for the treatment of type 1 diabetes ("T1D"), today reported financial results for the first quarter ended March 31, 2024, and provided an update on recent corporate developments.
“The first quarter of 2024 saw us reach several important milestones, which we believe... (continue reading...)
More Press Releases
View Older Stories-
AM Best Affirms Credit Ratings of Tokio Marine Canada Ltd.
-
23andMe to Report Q4 and Full Year FY2024 Financial Results
-
Nephros Announces Financial Results for Quarter Ended March 31, 2024
-
Geospace Technologies Corporation Reports Second Quarter and Six-Month 2024 Earnings
-
Pangaea Logistics Solutions Ltd. Reports Financial Results for the Quarter Ended March 31, 2024
-
Announcing the First-Ever MMO Awards, Hosted by Eiya
-
Dogness Announces Entry into US$5.0 Million Private Placement
-
Long Beach Economic Partnership Relaunches World Trade Center Long Beach
-
Innospec Reports First Quarter 2024 Financial Results
-
Sibelco Earns 2023 Safety Achievement Award from Essential Minerals Association
-
Pennington Celebrates Overlooked Plant Moms for Mother’s Day in Humorous Spot
-
Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
-
Celebrate Mother’s Day at South Coast Plaza
-
Corzo Cares Annual Free Car Seat Giveaway
-
Aimbridge Hospitality Names Eric B. Jacobs Chief Global Growth Officer
-
Smartsheet to Announce First Quarter of Fiscal Year 2025 Financial Results on June 5, 2024
-
LFL Group (Leon's Furniture Limited) Announces Election of Directors
-
Mawson Infrastructure Group Announces Hiring of Head of Corporate Strategy and Head of Corporate Development
-
Arcus Biosciences Announces New Employment Inducement Grants
-
Alcoa Corporation Declares Quarterly Cash Dividend
-
WineClubs.net Unveils the Ultimate 2024 Wine Club Gift Guide for Wine Enthusiasts
-
Runway Growth Finance Corp. Announces Secondary Offering of Common Stock by Selling Stockholder
-
B2i Digital is a Marketing Partner for The Reg A & Crowdfunding Conference and The SPAC Conference in Westchester County, NY
-
374Water Schedules First Quarter 2024 Earnings Release and Conference Call
-
Douglas Elliman Inc. Reports First Quarter 2024 Financial Results
-
C-COM Announces Issuance of Stock Options
-
Planet 13 Announces Q1 2024 Financial Results
-
Nephros Announces Financial Results for Quarter Ended March 31, 2024
-
EVI Industries Reports Third Quarter Results Including Record Cash Flows
-
Orezone Announces Planned Board Succession and New Board Nominee
-
Murphy USA Inc. Announces Dividend Increase
-
Silver Spike Investment Corp. Reports First Quarter 2024 Financial Results and Announces Cash Dividend of $0.25 Per Share
-
Sadot Group Inc. Announces First Quarter 2024 Conference Call
-
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress
-
Mercer International Inc. Reports First Quarter 2024 Results and Announces Quarterly Cash Dividend Of $0.075
-
ESAB Corporation Board Declares Increased Dividend
-
Butterfield 2024 Annual General Meeting Voting Results
-
Entravision Announces Leadership Appointments to Support Strategic Priorities
-
Theratechnologies Reports on its Annual Meeting of Shareholders
-
Materion Corporation Increases Quarterly Cash Dividend
-
indie Semiconductor Reports First Quarter 2024 Results
-
Mettler-Toledo International Inc. Reports First Quarter 2024 Results
-
JPMorgan Announces Results of Exchange Offer Relating to Its Alerian MLP Index ETNs and Reminds Holders That the Remaining AMJ ETNs Will Mature May 24, 2024
-
Bowlero Announces the Acquisition of Thunderbowl Lanes in Michigan
-
WYNDHAM HOTELS & RESORTS DECLARES QUARTERLY CASH DIVIDEND
-
National Safety Council Releases New Research on Location Geofencing Technology to Help Advance Workplace Safety
-
FMC Corporation announces multi-year collaboration with AgroSpheres
-
AKTIS ONCOLOGY TO PARTICIPATE IN THE 2024 GUGGENHEIM HEALTHCARE TALKS RADIOPHARMACEUTICALS DAY
-
Prologis Declares Quarterly Dividend
-
Agilysys POS Platform Approved For Marriott International Properties In U.S. And Canada